News

20 May 2026

Savita Oil Technologies Expands Synthetic Ester Capacity for Offshore Lubricants

Savita Oil Technologies has expanded synthetic ester manufacturing capacity at its Mahad facility to support growing demand in the offshore lubricants market. The expansion strengthens supply for offshore drilling, marine equipment, EV cooling fluids, immersion cooling, and high-performance industrial lubricant applications.

20 May 2026

Advancing Alzheimer's Care: Voyager's Tau-Silencing Gene Therapy Breakthrough

Voyager unveils a breakthrough tau-silencing gene therapy aimed at slowing Alzheimer’s progression with next-generation neurodegenerative care.

20 May 2026

Dr. Reddy’s and Nestlé Health Science launch Celevida GLP+ for people undergoing GLP-1/GIP therapy in India.

Dr. Reddy’s and Nestlé Health Science launched Celevida GLP+ in India to support nutrition and muscle health for patients receiving GLP-1/GIP therapy for obesity and type 2 diabetes.

20 May 2026

Haut.AI to introduce a new standard in skin measurement at New York Suppliers’ Day 2026

Haut.AI introduced its Face180° AI-powered skin measurement platform at New York Suppliers’ Day 2026, advancing personalized skincare, digital beauty, and AI-driven skin diagnostics.

20 May 2026

Dr. Reddy’s and Nestlé Health Science Launch Nutrition Product for Patients on Obesity Drugs.

Dr. Reddy’s and Nestlé Health Science introduced Celevida GLP+ to support nutrition and muscle health in patients using GLP-1 therapies for obesity and diabetes. Rising demand for personalized medical nutrition therapy is driving market growth.

19 May 2026

Protein Degraders Gain Speed as Arvinas Scores Landmark Approval.

Arvinas received landmark FDA approval for its PROTAC protein degrader therapy, marking a breakthrough in targeted protein degradation and precision medicine. Growing innovations in PROTACs and molecular glues are driving market growth.

19 May 2026

Stealth BioTherapeutics Provides Commercial Launch Update and Pipeline Progress Across Mitochondrial Disease Portfolio

Stealth BioTherapeutics reported strong early demand for FORZINITY, the first FDA-approved therapy for Barth syndrome. Growing innovation in mitochondrial medicine and biotherapeutics is driving market growth worldwide.

19 May 2026

Gallant Advances Stem Cell Therapy for Canine Osteoarthritis with FDA Expanded Approval Pathway

Gallant received expanded FDA conditional approval pathway eligibility for its canine osteoarthritis stem cell therapy. Positive pilot study results highlight growing demand for veterinary regenerative medicine and advanced pet treatments.

18 May 2026

Borealis And Borouge Expand Sustainable Polyolefin Solutions With Recleo

Borealis and Borouge introduced Recleo, a new global recycled plastics brand designed to support sustainable manufacturing and expand recycled polyolefin use across industries worldwide.

18 May 2026

INEOS Expands Sustainable Olefins Solutions With Recycled Polymer Innovation

INEOS introduced a new Recycl-IN polypropylene grade containing 70% recycled content to support sustainable cosmetics packaging and strengthen innovation across the global olefins market.

18 May 2026

CovationBio Expands Bio Based Chemicals Production in China

CovationBio completed a major milestone for its China biomaterials facility and launched Xatryx R bio based PTMEG products to support sustainable chemical manufacturing and reduce fossil resource dependence.

18 May 2026

Silal Group and Olive Gaea Planning to Launch AI-driven ESG platform in UAE

Silal Group and Olive Gaea are planning to launch an AI-driven ESG platform in the UAE to enhance sustainability tracking and carbon management.

20 May 2026

ABM Raises the Bar in Sustainable Cleaning with Industry-First ISSA Green Certification

ABM sets a new sustainability benchmark in facility services with the industry’s first ISSA Green Certification for eco-friendly cleaning practices.

18 May 2026

Swedish Scientists Advance Stem Cell Breakthrough for Type 1 Diabetes

Swedish scientists achieve a major stem cell breakthrough for Type 1 diabetes, advancing research toward innovative insulin-producing therapies.

18 May 2026

AlphaCore Amplifies Market Intelligence Strategy With Launch of “Upside Capture” Podcast Series

AlphaCore unveils the “Upside Capture” podcast series to deliver sharper market intelligence, investment insights, and strategic financial trends.

18 May 2026

How Automotive Is Converging Software, AI and EV Platforms in 2026, According to McKinsey and Gartner

Automakers are accelerating AI, software-defined vehicles, OTA updates, and EV platform integration to transform mobility in 2026.

18 May 2026

UK Logs Record EV Registrations in March

UK electric vehicle registrations surged in March as BEV demand rose sharply despite rising battery and charging costs.

18 May 2026

Tjoapack Expands in the U.S. and Europe

Tjoapack expands pharmaceutical end-of-line packaging capacity in the U.S. and Europe to support biologics and cold chain demand.

18 May 2026

Sarepta Announces First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1

Sarepta Therapeutics shares early clinical data for siRNA therapies targeting FSHD1 and DM1, advancing RNA-based rare disease treatments.

18 May 2026

Balrampur Chini Mills Bets Big on Green Growth in Uttar Pradesh with India’s Broader Strategy 

Balrampur Chini Mills boosts PLA bioplastics investment in Uttar Pradesh, supporting India’s green manufacturing and sustainable packaging growth.

18 May 2026

Medaptus Launches Command, a 24/7 Operational Command Center for Hospital Medicine 

Medaptus has launched Command, a healthcare command center platform designed to improve hospital operations, patient flow, provider assignments, and real-time workflow coordination across healthcare facilities.

18 May 2026

TRUQAP® (capivasertib) recommended by the FDA Advisory Committee for PTEN-deficient metastatic hormone-sensitive prostate cancer

AstraZeneca’s TRUQAP (capivasertib) has received positive support from the FDA Advisory Committee for treating PTEN-deficient metastatic hormone-sensitive prostate cancer in combination with abiraterone and ADT.

18 May 2026

EPIK Biosciences Launches to Pioneer Ketamine-Powered Psychedelic Therapies to Transform Treatment of Mental Health, Pain, and Addiction 

EPIK Biosciences has launched to develop ketamine-powered psychedelic therapies targeting mental health disorders, chronic pain, and addiction through advanced co-delivery formulations and NMDA receptor modulation.

15 May 2026

American Fusion Inc. Introduces Government Procurement Services with USD 58,000 Defense Contract

American Fusion launches government procurement services after securing a USD 58,000 defense contract in Canada.

15 May 2026

Karnataka Government Launches Kusuma Sanjeevini Programme for Hemophilia Patients

Karnataka launched the Kusuma Sanjeevini programme to improve preventive hemophilia care with prophylaxis treatment and specialized emergency support.

15 May 2026

Innovative Eyewear Launched Smart Safety Frames for Occupational Purposes

Innovative Eyewear launches Lucyd Armor Vantage smart safety glasses with ANSI certification, prescription support, and AI translation features.

15 May 2026

UNIQLO Unveils Cecilie Bahnsen Collaboration to Redefine Accessible Luxury in Women's Wear

UNIQLO partners with Cecilie Bahnsen to launch a luxury-inspired womenswear and kidswear collection for Spring-Summer 2026.

15 May 2026

OURVITA to unveil new nutra concepts spanning hydration, longevity, and gut health at Vitafoods Europe 2026 

Ourvita, Europe’s leading food supplements CDMO, is expanding its global footprint through innovative formulations, personalized nutrition solutions, and advanced manufacturing capabilities.

15 May 2026

LuxSci Launches Enterprise-Grade HIPAA Compliant Email Security for Mid-Sized Healthcare Organizations

LuxSci launched a HIPAA-compliant email security solution designed for mid-sized healthcare organizations, offering secure healthcare communications, encryption, and scalable cloud-based integration.

15 May 2026

Oxford BioTherapeutics and Bristol Myers Squibb Partner to Develop Next-Generation T-Cell Engagers

Oxford BioTherapeutics and Bristol Myers Squibb announced a strategic collaboration to develop next-generation T-cell engagers for solid tumors using advanced oncology and antibody engineering platforms.